Best Addiction and Substance Abuse Grants in Ohio

The OneOhio Recovery Foundation is dedicated to addressing the opioid epidemic by allocating funds from pharmaceutical settlements to enhance substance misuse prevention, treatment, and recovery initiatives across Ohio. For Regional Grant Cycle #2, the Board authorized $40 million to support evidence-based investments in local communities. This funding model aims to create sustainable impacts while ensuring fiscal responsibility and transparency in managing resources for long-term recovery efforts.

The Integrated Maternal Wellness Pilot Project, initiated by the Ohio Department of Behavioral Health, aims to enhance integrated health care services for pregnant and parenting women struggling with substance use disorders in Northwestern and Western rural Ohio. This initiative seeks applicants to collaborate with a consultant to implement the MATernity Journey framework, focusing on increasing access to care and improving health outcomes for this vulnerable population.

The Ohio Department of Behavioral Health is seeking qualified hospital systems in rural counties to participate in the MATernity Journey: Integrated Maternal Wellness Framework. This initiative aims to enhance integrated care and expand comprehensive health services for pregnant and parenting women in Northwestern and Western Ohio. By partnering with local programs, this project seeks to improve health outcomes and accessibility for this vulnerable population, fostering a supportive environment for maternal wellness.

The OneOhio Recovery Foundation's Regional Grant Cycle 2 aims to fund organizations addressing substance use disorders in Ohio. This initiative supports local efforts in prevention, treatment, and recovery, utilizing a portion of funds from the pharmaceutical industry due to the opioid crisis. Eligible applicants must align their proposed services with the foundation's approved purposes, ensuring a direct benefit to individuals with substance use disorders and their families.

Ohio District Kiwanis Foundation

The Ohio District Kiwanis Foundation was established in 1982 as a charitable not for profit corporation which accepts gifts from various sources to help the needs of the Ohio Kiwanis community.

All active, privileged, and senior members of the Ohio District of Kiwanis are automatically voting members of the Foundation which is governed by a Board of Trustees.

Funds earmarked for specific projects will be collected and distributed only to those projects. Funds which are not designated for specific projects are invested and only the proceeds of these investments may be used to help meet our mission. In accordance with IRS statute 501(c)3, donations, gifts, bequests of money or property to the Ohio District Kiwanis Foundation are tax-exempt.

Mini Grant Program

The Ohio District Foundation has a mini grant program available to Kiwanis Clubs. There is a required match for each grant. The mini grants are to be used for new club service projects that focus on the Foundation's areas of focus for Safe and Healthy Kids. These are: Bike Safety, Water Safety, Internet Safety, Fire Safety, Food and Nutrition programs, Mental health, bullying prevention, and drug addiction  

The Siletz Tribal Charitable Contribution Fund, established by the Confederated Tribes of Siletz Indians, has distributed over $16.3 million in grants since 1999. It supports charitable organizations and local governments in eleven Oregon counties, as well as Native American initiatives across the U.S. The fund prioritizes education, health, public safety, addiction prevention, housing, arts, and environmental preservation, ensuring the Tribe's commitment to community support and cultural heritage.

Who is OCJS

The Ohio Office of Criminal Justice Services (OCJS) is a division of the Ohio Department of Public Safety. By statute, OCJS is the lead justice planning and assistance office for Ohio, administering millions of dollars in state and federal criminal justice funding every year. OCJS also evaluates programs and products, develops training, resources, and best practices for criminal justice professionals and communities. OCJS has been designated by Governor Mike DeWine to administer the FY 2025, Residential Substance Abuse Treatment Program for State Prisoners (RSAT). The RSAT funds are used to support treatment services in addition to the services the prison or jail is already required to provide.

Residential Substance Use Disorder Treatment Grant Program Request For Proposals

The goal of the RSAT Program is to prepare individuals for reintegration into communities by delivering community-based treatment and other broad-based aftercare services. RSAT assists states and units of local government in developing and implementing residential substance abuse treatment programs within state correctional facilities, local correctional, detention facilities, and juvenile detention centers where inmates are incarcerated for a period of time sufficient to permit substance abuse treatment. OCJS recommends applicants target high-risk offenders as program participants. RSAT funds may be used to implement four types of programs: residential, jail-based, aftercare, and jail-based pretrial SUD treatment programs. A minimum of 10 percent of Ohio’s RSAT allocation must be available for local correctional and detention facilities for any of the three following program areas:

Residential Substance Use Disorder Treatment

• Engage participants for a period between six (6) and 12 months.
• Establish a therapeutic community (i.e., program participants are set apart from the general population). Therapeutic Communities are residential treatment facilities that are set apart from the general correctional population in either a separate facility or a dedicated housing unit that is used exclusively for RSAT and/or other SUD treatment programs.
• Focus on the inmate’s substance use diagnosis and addiction-related needs.
• Develop the inmate’s cognitive, behavioral, social, vocational, and other skills necessary to solve the substance use and related problems.
• Require urinalysis and/or other proven reliable forms of drug and alcohol testing for program participants, including both periodic and random testing, and for former participants while they remain in the custody of the state or local government.
• Prepare participants for successful community reintegration, including post-release referral to appropriate
• evidence-based aftercare treatment and service providers that support the use of medication-assisted treatment.

Jail-Based Substance Use Disorder Treatment

• Engage participants for at least three (3) months.
• Focus on inmate’s substance use diagnosis and addiction-related needs.
• Develop the inmate’s cognitive, behavioral, social, vocational, and other skills to solve the substance use and related problems.
• Require urinalysis and/or other proven reliable forms of drug and alcohol testing for program participants, including both periodic and random testing, and for former participants while they remain in the custody of the state or local government.
• Prepare participants for successful community reintegration, including post-release referral to appropriate evidence-based aftercare treatment and service providers that support the use of medication-assisted treatment.
• Jails that do not have the capacity to establish a therapeutic community are encouraged to group RSAT program participants within the general correction setting.

Aftercare

• Projects must provide aftercare services. These services must involve coordination between the correctional treatment program and other social service and rehabilitation programs, such as education and job training, parole supervision, halfway houses, self-help, and peer group programs. To qualify as an aftercare program, the head of the substance abuse treatment program must work in conjunction with state and local authorities and organizations involved in substance abuse treatment to assist in the placement of program participants into community substance abuse treatment facilities on release
• Jail-based pretrial SUD treatment programs
• Projects that initiate or continue evidence-based SUD treatment programs, including medication-assisted treatment, in pretrial populations during their confinement and/or foster connections to SUD treatment in the community upon pretrial release. Programs supporting pre-trial populations do not need to meet above criteria for jail-based residential SUD treatment programs.

The RecoveryOhio Law Enforcement Fund, managed by the Ohio Office of Criminal Justice Services, aims to combat the drug epidemic and mental health crisis in Ohio. This funding supports law enforcement initiatives that emphasize prevention, harm reduction, and treatment for underserved populations. By promoting effective strategies, training, and collaboration, the fund seeks to enhance community responses and improve outcomes for individuals affected by substance use disorders and mental illness.

Women's Residential ASAM Pilot Grant

DBH is seeking information in providing funding opportunities to non-profit organizations serving ASAM level of cares 3.5 and 3.7, interested in providing more information to DBH regarding the Women’s Residential ASAM Pilot Grant, to access funding for developing ASAM 4th edition co-occurring enhanced (COE) services and biomedically (BIO) enhanced services at the 3.5 and 3.7 levels of care. The target population for these funds are pregnant and postpartum women with substance use disorders.  Funds must be used for any expenses used to establish these services including, hiring appropriately credentialled staff for COE and BIO enhanced services, purchasing medical equipment necessary for BIO enhanced services, and providing housing for women and their children.

Women's Hub and Spoke Grant

DBH is seeking information in providing funding opportunities to non-profit organizations serving pregnant and postpartum women, interested in providing more information to DBH regarding the Women’s Hub and Spoke Grant, to access funding to strengthen and expand integrated, evidence-based substance use disorder (SUD) and maternal behavioral health services. The program seeks to improve maternal and infant health outcomes by addressing SUD and co-occurring substance use and mental health conditions through comprehensive screening, treatment, recovery supports, and workforce development. This opportunity may provide up to $500,000 for facilities that are already appropriately licensed and certified by the DBH in Ohio communities. Funds must be used for any expenses in developing a hub-and-spoke maternal care model in areas with little maternal healthcare integration. Expenses may include, hiring appropriately credentialed staff to fulfill hub and spoke requirements, early identification of women through evidence-based screening tools, timely enrollment, care coordination, and MAT/MOUD workforce expansion to train and mentor healthcare professionals with prescribing authority for buprenorphine and naltrexone products. All grant recipients are expected to participate in a Six Sigma systems improvement process that will bring alignment among stakeholders around creating a safer, more coordinated, and more compassionate care journey for perinatal women.

The National Institutes of Health (NIH) is inviting applications for the Screening, Brief Intervention, and Referral to Treatment or Prevention (SBIRT/P) program. This funding opportunity aims to explore innovative methods for addressing alcohol, tobacco, and other drug use among adults facing health disparities. The initiative seeks research proposals that will implement and evaluate SBIRT/P strategies in collaboration with healthcare and community partners. This approach is crucial for enhancing public health and ensuring effective interventions.

The Elevance Health Foundation's Behavioral Health Grant aims to address significant challenges in mental health and substance use disorders. With a commitment of up to $90 million over three years, the Foundation seeks partnerships with nonprofits to enhance treatment access, promote prevention strategies, and alleviate loneliness among affected individuals. This initiative emphasizes innovative solutions and measurable outcomes, targeting both national and local programs, particularly in states with pressing health disparities.

The AmeriHealth Caritas Foundation Grant aims to prevent and mitigate adverse childhood experiences (ACEs) to promote healthier outcomes for children. With a focus on empowering families, healing behaviors, and access to healthcare, the foundation supports nonprofit organizations that provide comprehensive care and resources. Grants range from $100,000 to $250,000, totaling up to $1.945 million for project-specific initiatives. Eligible organizations must be 501(c)(3) nonprofits operating in states where AmeriHealth Caritas Medicaid markets exist.

The US Department of Health & Human Services, through the NIH, invites applications for innovative approaches to implement SBIRT/P for addressing alcohol, tobacco, and other drug use in adults facing health disparities. This funding opportunity encourages research that tests screening, brief interventions, and referrals for treatment or prevention services. Applications are due on specified deadlines from February 2024 through March 2027, fostering collaboration with healthcare and community partners to enhance public health outcomes.

The CNX Foundation Grant aims to enhance the Appalachian region through strategic investments totaling $30 million. With a focus on sustainability and community development, the grant addresses pressing socio-economic challenges such as food insecurity, health and wellness for children, and technological access. By fostering local initiatives, CNX Foundation aspires to create measurable impacts that uplift communities and promote long-term growth, embodying their commitment to environmental, social, and governance principles.

The ADAMH Community Mini-Grant Program supports non-profit and faith-based organizations in Franklin County with grants up to $5,000. The program aims to foster community impact by raising awareness of behavioral health issues, promoting prevention, reducing stigma, enhancing social connectedness, and educating about diversity, equity, and inclusion. Eligible organizations must have 501c3 status or be tax-exempt schools, and priority is given to those not currently supported by ADAMH.

The National Cooperative Drug/Device Discovery/Development Groups (NCDDG) program invites applications to foster innovative research in treating mental disorders and substance use issues. This initiative promotes collaboration between academia and industry, supporting diverse, multidisciplinary projects aimed at developing rational therapies and neurostimulation techniques. Applicants are encouraged to submit Letters of Intent 30 days before the proposal deadline to enhance project alignment with funding goals.

This funding opportunity invites Small Business Technology Transfer (STTR) grant applications aimed at developing FDA-regulated medical products for patients with opioid and stimulant use disorders. Projects may focus on pharmacotherapeutics or diagnostic devices, including software. The initiative seeks to address the ongoing opioid crisis by supporting innovations that enhance treatment options for individuals and communities affected by these disorders.

The NCDDG program supports innovative research aiming to discover and develop new treatments for mental disorders, including substance use and alcohol use disorders. This initiative encourages collaborations between academic and industry partners to advance neurostimulation techniques and drug/device development. Applicants are invited to submit proposals that focus on specific projects utilizing the U01 mechanism, with a clear emphasis on rationally designed candidate agents and cutting-edge technologies. Letters of Intent are encouraged 30 days prior to the submission deadline.

The Opioid Crisis Response Program Fellowship, offered by Equal Justice Works, addresses the opioid epidemic by mobilizing public interest lawyers to provide vital civil legal aid to underserved communities affected by Opioid Use Disorder. This two-year fellowship enables attorney fellows to advocate for clients' rights, reduce barriers to treatment, and enhance community education about legal impacts. Through collaboration with various stakeholders, the program aims to improve health outcomes and foster systemic change in the fight against this public health crisis.

The HEAL Initiative's Career Development Awards aim to empower early career researchers and clinicians in implementation science. By providing training and funding, this initiative seeks to address substance use prevention and treatment through research projects that align with the HHS Overdose Prevention Strategy. Focused on vital areas such as opioid prescribing, OUD treatment, and recovery support, the program aspires to cultivate a new generation of experts who will significantly impact addiction clinical practices and mentorship.

The NIH R25 program aims to enhance inclusivity in research education by supporting activities that encourage individuals from diverse backgrounds to pursue careers in substance use and addiction sciences. This initiative focuses on skills development courses and research experiences, particularly targeting underrepresented groups in biomedical and behavioral sciences. Applications are due by 5:00 PM local time of the applicant organization, with optional Letters of Intent encouraged 30 days prior to the full proposal deadline.

The Substance Use/Substance Use Disorder Dissertation Research Award supports doctoral candidates in completing their dissertation research on substance use disorders. This initiative encourages diverse applicants and aligns with NIDA funding priorities. Key deadlines include February 16 and June 16 of 2025 and 2026 for standard applications, with specific dates for renewal and AIDS-related projects. This funding aims to enhance the research workforce in the field.

The NIDA Mentored Clinical Scientist Development Program Award aims to foster research independence in clinician scientists by providing intensive supervised research training and career development in the field of substance use and substance use disorder. Applications are due by 5:00 PM local time of the applicant organization, ensuring timely submission for this essential funding opportunity.

The High Priority HIV and Substance Use Research funding opportunity aims to support innovative research that addresses the intersection of HIV and substance use. Researchers are encouraged to submit proposals that include a detailed research plan and preliminary data, exploring new avenues for prevention, treatment, and potential cures for HIV among people who use drugs. Applications are due by 5 PM local time, with optional Letters of Intent recommended 30 days prior.

The Chemical Countermeasures Research Program (CCRP) Initiative aims to support vital research on the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids, including fentanyl and its combinations. This funding opportunity encourages studies that enhance understanding and mitigation strategies for these substances, focusing on both immediate and long-term health impacts. Applications are due by 5:00 PM local time, with optional Letters of Intent accepted 30 days prior to the proposal deadline.

The Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) aims to enhance research in Anesthesia, Addiction Medicine, and Pain Medicine. It focuses on critical areas such as clinical trial endpoints for chronic pain, outcome measures in stimulant use disorders, and neurodevelopmental assessments in pediatric patients. The initiative encourages applicants to propose comprehensive, evidence-based plans to improve the prescribing of analgesic and anesthetic drug products, with multiple awards available.